Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LaVision BioTec is a German life science tools company focused on advanced microscopy and imaging systems for research applications. The company developed and manufactured light-sheet, multiphoton, and confocal microscopy platforms used in neuroscience, immunology, oncology, developmental biology, and spatial biology research. Its flagship product families included the UltraMicroscope light-sheet systems and TriM Scope multiphoton microscopes, along with associated software and image-processing capabilities. Founded as a spin-off from the University of Bielefeld and LaVision GmbH, the company was acquired by Miltenyi Biotec in 2018. As of September 2023, LaVision BioTec GmbH was formally integrated and operates as part of Miltenyi Biotec B.V. & Co. KG, with continued development and manufacturing activities in Bielefeld and Göttingen, Germany.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LaVision BioTec.